Table 4.
Basic analysis results.
| Project | Cumulative cost(¥) | Cumulative effectiveness (QALYs) | Incremental cost | Incremental effectiveness | ICER (¥/QALY) |
|---|---|---|---|---|---|
| BUD/FORa | 173,030.05 | 7.73 | |||
| FF/UMEC/VIb | 199,765.55 | 8.54 | 26,735.50 | 0.81 | 33,006.80 |
Fluticasone/umeclidinium/vilanterol triple combination.
Budesonide/formoterol double combination.